Obtaining the recombinant fusion protein OprF-aTox of Pseudomonas aeruginosa whith protective properties
Abstract
Into the cells of Escherichia coli (strain BL21(DE3)) two forms of the fusion protein Pseudomonas aeruginosa containing the full length outer membrane protein F (OprF) and nontoxic form of Exotoxin A (without 106 C-terminal amino acid residues) have been synthesized. Two recombinant genes were inserted into plasmid pET28 in different order: oprF-atox and atox-oprF. Only oprF-atox variant allowed to obtain the recombinant protein sufficient for purification by affinity chromatography on Ni-Sepharose. The recombinant fusion protein OprF-aTox showed a high specificity in interaction with the preparations of polyclonal immune rabbit serum to the recombinant OprF, the recombinant nontoxic form of Exotoxin A and the bacterial cells of P. aeruginosa. The purified recombinant fusion protein OprF-aTox after two immunizations protected the mice against toxigenic strain of P. aeruginosa (РА-103) being injected intraperitoneally. The index of efficiency of protective properties of OprF-aTox in the optimal dose (50 µg protein per mouse) was 3.5. This was more efficient than in cases when the recombinant OprF and the recombinant toxoid were injected separately. The indexes of efficiency of protective properties of OprF and the toxoid were 2.1 and 2.0.
About the Authors
A. V. Soldatenkova
I. Mechnikov Research Institute of Vaccines and Sera
Russian Federation
Researcher of Laboratory of protective antigens
Russian Federation
Researcher of Laboratory of protective antigens
N. A. Mihailova
I. Mechnikov Research Institute of Vaccines and Sera
Russian Federation
Deputy Director General for the scientific work, head of Laboratory of protective antigens. Doctor of Medical Sciences, professor
Russian Federation
Deputy Director General for the scientific work, head of Laboratory of protective antigens. Doctor of Medical Sciences, professor
E. M. Zimina
I. Mechnikov Research Institute of Vaccines and Sera
Russian Federation
Junior researcher of Laboratory of protective antigens
Russian Federation
Junior researcher of Laboratory of protective antigens
E. I. Leonova
I. Mechnikov Research Institute of Vaccines and Sera
Russian Federation
Junior researcher of Laboratory of protective antigens
Russian Federation
Junior researcher of Laboratory of protective antigens
A. A. Kaloshin
I. Mechnikov Research Institute of Vaccines and Sera
Russian Federation
Leading researcher of Laboratory of protective antigens. Candidate of Biological Sciences
Russian Federation
Leading researcher of Laboratory of protective antigens. Candidate of Biological Sciences
References
1. Rudnov VA. Antibiotic treatment of hospital infections caused by P. aeruginosa. Russkiy meditsinskiy zhurnal 2005; 13(7): 485–90 (in Russian).
2. Ilyukevich GV. Pseudomonas infection: the new century with an old problem. Meditsinskie novosti 2004; (12): 3–8.
3. Lazareva AV, Tchebotar IV, Kryzhanovskaya OA, Tchebotar VI, Mayanskiy NA. Pseudomonas aeruginosa: Pathogenicity, Pathogenesis and Diseases. Klinicheskaya mikrobiologiya i antimikrobnaya himioterapiya 2015; 17(3): 170–86.
4. Bobrovnichy VI. Modern approaches to diagnosis and treatment of Pseudomonas aeruginosa infection in a patient with cystic fibrosis. Meditsinskiy zhurnal 2012; 1(36): 4–9.
5. Kaloshin AA, Gatypova EV, Mikhailova NA. Obtaining recombinant forms of outer membrane protein F (OprF) of Pseudomonas aeruginosa and assessment of their immunogenic properties. Biotekhnologiya 2011; (2): 74–84.
6. Kaloshin AA, Isakov MA, Mikhailova NA, Vertiev YuV. Preparation of Recombinant Atoxic Form of Exotoxin A from Pseudomonas aeruginosa. Bulleten eksperimentalnoy biologii i meditsiny 2012; 154(9): 330–5.
7. Vertiev YuV, Brodinova NS, Moroz AF. Pseudomonas aeruginosa exotoxin A and its role in the pathogenesis of pyocyaneus infection. Zhurnal mikrobiologii, epidemiologii i immunobiologii 1981; (2): 13–9.
8. Stanislavskii ES, Zhvanetskaia MI, Mashilova GM, Gladus MA. Cell-free pseudomonas vaccine. I. Enzyme properties and virulence of strains of P. aeruginosa; protective activity of their water-soluble antigens. Zhurnal mikrobiologii, epidemiologii i immunobiologii 1980; (8): 66–72.
Review
For citations:
Soldatenkova A.V., Mihailova N.A., Zimina E.M., Leonova E.I., Kaloshin A.A. Obtaining the recombinant fusion protein OprF-aTox of Pseudomonas aeruginosa whith protective properties. BIOpreparations. Prevention, Diagnosis, Treatment. 2016;16(2):96-100. (In Russ.)
Views:
614
Email this article 